Cutler Group LP Dexcom Inc Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Dexcom Inc stock. As of the latest transaction made, Cutler Group LP holds 9,500 shares of DXCM stock, worth $630,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,500

Previous 455 1987.91%

Holding current value

$630,135

Previous $56,000 98.21%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$75.49 - $124.16 $34,347 - $56,492	455 New	455 $56,000
Q2 2023 Jul 18, 2023	SELL	$112.47 - $130.98 $11,696 - $13,621	-104 Reduced 6.86%	1,412 $181,000
Q1 2023 May 01, 2023	SELL	$104.0 - $122.92 $14,976 - $17,700	-144 Reduced 8.67%	1,516 $176,000
Q4 2022 Feb 07, 2023	SELL	$84.98 - $122.67 $226,471 - $326,915	-2,665 Reduced 61.62%	1,660 $187,000
Q3 2022 Oct 25, 2022	SELL	$76.35 - $94.18 $89,711 - $110,661	-1,175 Reduced 21.36%	4,325 $348,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $367,146 - $717,605	5,400 Added 5400.0%	5,500 $409,000
Q1 2022 Apr 14, 2022	SELL	$94.08 - $130.2 $37,632 - $52,079	-400 Reduced 80.0%	100 $51,000
Q4 2021 Jan 18, 2022	SELL	$129.87 - $162.82 $272,727 - $341,922	-2,100 Reduced 80.77%	500 $268,000
Q3 2021 Oct 26, 2021	BUY	$106.71 - $143.18 $277,446 - $372,268	2,600 New	2,600 $1.42 Million
Q4 2018 Feb 05, 2019	SELL	$26.99 - $37.37 $29,689 - $41,107	-1,100 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$23.35 - $36.72 $25,685 - $40,392	1,100 New	1,100 $157,000
Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $43,646 - $61,960	-3,342 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$11.12 - $15.38 $24,897 - $34,435	2,239 Added 202.99%	3,342 $191,000
Q3 2017 Oct 17, 2017	BUY	$11.36 - $18.98 $12,530 - $20,934	1,103	1,103 $53,000

Others Institutions Holding DXCM

# of Institutions

1,088

Shares Held

353M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account